B*44 restricted peptides for use in immunotherapy against cancers and related methods
US-11208448-B2 · Dec 28, 2021 · US
Linear peptides containing only normal peptide links
Linear peptides containing only normal peptide links · Cooperative Patent Classification (CPC)
Chemical and metallurgical processes, compounds, and materials.
Related technology areas
Mapped technology topics for this CPC code.
| Metric | Value |
|---|---|
| CPC code | C07K7/04 |
| Official title | Linear peptides containing only normal peptide links |
| Display label | Linear peptides containing only normal peptide links |
| Total patents | 104 |
Filing trend
Year-over-year patent counts classified under this CPC code.
Filing activity over the last five years is rapidly declining.
| Year | Patents |
|---|---|
| 2015 | 3 |
| 2016 | 7 |
| 2017 | 7 |
| 2018 | 6 |
| 2019 | 6 |
| 2020 | 18 |
| 2021 | 14 |
| 2022 | 12 |
| 2023 | 20 |
| 2024 | 7 |
| 2025 | 1 |
| 2026 | 3 |
Representative patents
Representative publications under this CPC code from precomputed stats, or recent filings when stats are unavailable.
Brevican-Binding Peptides for Brain Tumor Imaging
US-2021353708-A1 · Nov 18, 2021 · US
B*44 restricted peptides for use in immunotherapy against cancers and related methods
US-11155590-B2 · Oct 26, 2021 · US
Heterologous targeting peptide grafted aavs
US-2021324044-A1 · Oct 21, 2021 · US
B*44 restricted peptides for use in immunotherapy against cancers and related methods
US-2021277080-A1 · Sep 9, 2021 · US
B*44 restricted peptides for use in immunotherapy against cancers and related methods
US-11111281-B2 · Sep 7, 2021 · US
B*44 restricted peptides for use in immunotherapy against cancers and related methods
US-2021230240-A1 · Jul 29, 2021 · US
Heterologous targeting peptide grafted AAVS
US-11014976-B2 · May 25, 2021 · US
B*44 restricted peptides for use in immunotherapy against cancers and related methods
US-11014972-B2 · May 25, 2021 · US
B*44 restricted peptides for use in immunotherapy against cancers and related methods
US-2021094992-A1 · Apr 1, 2021 · US
Peptides and methods for treatment of neurodegenerative diseases
US-2021060116-A1 · Mar 4, 2021 · US
B*44 restricted peptides for use in immunotherapy against cancers and related methods
US-10899811-B2 · Jan 26, 2021 · US
B*44 restricted peptides for use in immunotherapy against cancers and related methods
US-10899810-B2 · Jan 26, 2021 · US
B*44 restricted peptides for use in immunotherapy against cancers and related methods
US-2020399334-A1 · Dec 24, 2020 · US
Conformation switchable antimicrobial peptides and methods of using the same
US-2020399319-A1 · Dec 24, 2020 · US
Nucleotide sequences encoding peptide linkers
US-2020392512-A1 · Dec 17, 2020 · US
B*44 restricted peptides for use in immunotherapy against cancers and related methods
US-2020392194-A1 · Dec 17, 2020 · US
Peptides and methods for treatment of neurodegenerative diseases
US-10864244-B2 · Dec 15, 2020 · US
B*44 restricted peptides for use in immunotherapy against cancers and related methods
US-2020339644-A1 · Oct 29, 2020 · US
B*44 restricted peptides for use in immunotherapy against cancers and related methods
US-2020339646-A1 · Oct 29, 2020 · US
Frequently asked questions
Answers are generated from the same data shown on this page.
- What is CPC C07K7/04?
- CPC C07K7/04 is the Cooperative Patent Classification code for “Linear peptides containing only normal peptide links.”
- How many patents are filed under CPC C07K7/04 (Linear peptides containing only normal peptide links)?
- Our database includes 104 publications tagged with this CPC code.
- Is patent activity under CPC C07K7/04 growing?
- Publication counts under this code: 7 in 2024 vs 1 in 2025 (latest complete years).